Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition
Resource MedicinalProductDefinition "mpbe76bdf784deea6950583b234f789db2"
Profile: MedicinalProductDefinition (ePI)
identifier: id: EU/1/13/853/001, id: 0xF79CABF272B6A7EEF104DDDA44E82718
type: Medicinal Product (Medicinal Product Type#MedicinalProduct)
domain: Human use (Medicinal Product Domain#Human)
status: active (PublicationStatus#active)
legalStatusOfSupply: Medicinal product subject to medical prescription (rmswi#100000072084)
name
productName: Remsima 100 mg powder for concentrate for solution for infusion
type: Full name (220000000000#220000000001)
part
part: Remsima
type: Invented name part (220000000000#220000000002)
part
part: Infliximab
type: Scientific name part (220000000000#220000000003)
part
part: 100 mg
type: Strength part (220000000000#220000000004)
part
part: powder for concentrate for solution for infusion
type: Pharmaceutical dose form part (220000000000#220000000005)
Usages
Country Jurisdiction Language United Kingdom (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#GBR) United Kingdom (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#GBR) English (Tags for the Identification of Languages#en)